Orchestra BioMed Holdings, Inc. Debt Securities, Available-for-sale
Orchestra BioMed Holdings, Inc. (OBIO) had Debt Securities, Available-for-sale of $89.49 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2026-08-10
- 2026-06-30: Debt Securities, Available-for-sale $89.49M.
- 2026-03-31: Debt Securities, Available-for-sale $66.03M.
- 2025-12-31: Debt Securities, Available-for-sale $71.82M.
- 2025-09-30: Debt Securities, Available-for-sale $53.81M.
| Period end | Debt Securities, Available-for-sale |
|---|---|
| 2026-06-30 | $89.49M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $66.03M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $71.82M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $53.81M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $15.18M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $31.54M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $44.55M 10-K · filed 2026-03-12 |
| 2024-09-30 | $41.32M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $41.47M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $51.69M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $56.97M 10-K · filed 2025-03-31 |
| 2023-09-30 | $89.41M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $101.30M 10-Q · filed 2023-08-10 |
| 2022-12-31 | $63.91M 10-K · filed 2024-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |